The intracranial stents market size has grown rapidly in recent years. It will grow from $0.54 billion in 2025 to $0.63 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increasing incidence of intracranial aneurysms, rising prevalence of cerebrovascular diseases, improvements in endovascular treatment techniques, expansion of neurology specialty care centers, growing adoption of minimally invasive neurointerventions.
The intracranial stents market size is expected to see rapid growth in the next few years. It will grow to $1.13 billion in 2030 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to increasing demand for advanced neurovascular devices, rising focus on early stroke intervention, expansion of precision neurology treatments, growing investments in neurovascular R&D, increasing use of next-generation stent technologies. Major trends in the forecast period include increasing adoption of neurovascular stenting procedures, rising use of stent-assisted coil embolization, growing demand for biodegradable stent materials, expansion of advanced neuroimaging-guided interventions, enhanced focus on stroke and aneurysm management.
The anticipated rise in the incidence of brain aneurysms is poised to drive the growth of the intracranial stents market in the coming years. Characterized by the development of a bulge in the blood vessels of the brain, a brain aneurysm poses the risk of rupture, leading to brain hemorrhage and potential fatality. Intracranial vessel stenting (IVS) emerges as a minimally invasive treatment for addressing serious cerebral artery stenosis, a condition involving the weakening of arteries delivering blood to the brain. Reports indicate that approximately 3.2% of individuals worldwide have unruptured aneurysms, underscoring the significance of the increasing incidence of brain aneurysms in driving the growth of the intracranial stents market.
Major companies operating in the intracranial stents market are introducing new products such as the Pegasus HPC stent system to improve profitability and market positioning. The Pegasus HPC stent system is a medical device designed for patients with intracranial aneurysms and intracranial atherosclerotic disease (ICAD), enabling endovascular repair of the vessel neck and intracranial arteries. For example, in June 2023, Fluid Biomed, a Canada-based medical device company, carried out the first human implantation of its ReSolv polymer-metal hybrid flow-diverting stent for the treatment of intracranial aneurysms. According to the company, the device integrates a bioabsorbable polymer scaffold with a metal framework, delivering structural support while promoting vessel healing. This development marks a significant technological advancement in the intracranial stents market, as it is intended to lower long-term implant burden and enhance patient outcomes compared with conventional permanent stents.
In October 2024, Grand Pharmaceutical Group Limited, a China-based pharmaceutical and medical device company, partnered with Nanjing Kainite Medical Technology Co., Ltd. to jointly develop an adjustable intracranial stent retriever product named “Luci.” With this partnership, the companies aim to advance stroke intervention technologies and strengthen their presence in the neurovascular device market. Nanjing Kainite Medical Technology Co., Ltd. is a China-based medical technology company specializing in the research and development of innovative neurointerventional devices.
Major companies operating in the intracranial stents market are Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Abbott Laboratories, Terumo Corporation, Balt Extrusion, Acandis GmbH, Phenox GmbH, Rapid Medical Ltd, Penumbra Inc, MicroPort Scientific Corporation, Johnson & Johnson, Cook Medical LLC, Biotronik SE & Co KG, Cardionovum GmbH, InspireMD Inc, Admedes Schuessler GmbH, Kaneka Corporation, W L Gore & Associates Inc, Cerebral Stents.
North America was the largest region in the intracranial stents market in 2025. Asia-Pacific is expected to be the fastest region in the intracranial stents market share during the forecast period. The regions covered in the intracranial stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intracranial stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the intracranial stents market by increasing costs of imported nitinol alloys, polymer coatings, precision manufacturing equipment, and neurointerventional accessories. Neurovascular treatment centers in North America and Europe are most affected due to dependence on imported high-specification stents, while Asia-Pacific faces cost pressures on device manufacturing and distribution. These tariffs are increasing procedure costs and limiting rapid adoption of newer devices. However, they are also promoting domestic stent manufacturing, regional sourcing of materials, and innovation in cost-efficient neurovascular implants.
The intracranial stents market research report is one of a series of new reports that provides intracranial stents market statistics, including intracranial stents industry global market size, regional shares, competitors with a intracranial stents market share, detailed intracranial stents market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial stents industry. This intracranial stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Intracranial stents are tubular devices placed inside blood vessels, canals, or ducts, primarily used for treating intracranial stenosis and brain aneurysms by opening blocked arteries.
The primary types of intracranial stents include self-expanding stents, balloon-expanding stents, and stent-assisted coil embolization. Self-expanding stents expand autonomously after insertion into the intended lumen, such as a blood vessel or organ. Balloon-expanding stents, also known as balloon-expandable stents, offer higher radial stiffness and more precise placement, designed to address restenosis in the iliac artery by opening clogged arteries and restoring blood flow. Stent-assisted coil embolization plays a role in stabilizing coils within an aneurysm, providing support for coil deposition while preventing coil herniation into the parent vessel lumen. These intracranial stents are applied in the treatment of conditions such as brain aneurysms and intracranial stenosis, and find utilization in various sectors including hospitals, ambulatory surgery centers, and others.
The intracranial stents market consists of sales of Neuroform stents, Solitaire, Enterprise, and Leo plus, and Wingspan stent. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The intracranial stents market size is expected to see rapid growth in the next few years. It will grow to $1.13 billion in 2030 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to increasing demand for advanced neurovascular devices, rising focus on early stroke intervention, expansion of precision neurology treatments, growing investments in neurovascular R&D, increasing use of next-generation stent technologies. Major trends in the forecast period include increasing adoption of neurovascular stenting procedures, rising use of stent-assisted coil embolization, growing demand for biodegradable stent materials, expansion of advanced neuroimaging-guided interventions, enhanced focus on stroke and aneurysm management.
The anticipated rise in the incidence of brain aneurysms is poised to drive the growth of the intracranial stents market in the coming years. Characterized by the development of a bulge in the blood vessels of the brain, a brain aneurysm poses the risk of rupture, leading to brain hemorrhage and potential fatality. Intracranial vessel stenting (IVS) emerges as a minimally invasive treatment for addressing serious cerebral artery stenosis, a condition involving the weakening of arteries delivering blood to the brain. Reports indicate that approximately 3.2% of individuals worldwide have unruptured aneurysms, underscoring the significance of the increasing incidence of brain aneurysms in driving the growth of the intracranial stents market.
Major companies operating in the intracranial stents market are introducing new products such as the Pegasus HPC stent system to improve profitability and market positioning. The Pegasus HPC stent system is a medical device designed for patients with intracranial aneurysms and intracranial atherosclerotic disease (ICAD), enabling endovascular repair of the vessel neck and intracranial arteries. For example, in June 2023, Fluid Biomed, a Canada-based medical device company, carried out the first human implantation of its ReSolv polymer-metal hybrid flow-diverting stent for the treatment of intracranial aneurysms. According to the company, the device integrates a bioabsorbable polymer scaffold with a metal framework, delivering structural support while promoting vessel healing. This development marks a significant technological advancement in the intracranial stents market, as it is intended to lower long-term implant burden and enhance patient outcomes compared with conventional permanent stents.
In October 2024, Grand Pharmaceutical Group Limited, a China-based pharmaceutical and medical device company, partnered with Nanjing Kainite Medical Technology Co., Ltd. to jointly develop an adjustable intracranial stent retriever product named “Luci.” With this partnership, the companies aim to advance stroke intervention technologies and strengthen their presence in the neurovascular device market. Nanjing Kainite Medical Technology Co., Ltd. is a China-based medical technology company specializing in the research and development of innovative neurointerventional devices.
Major companies operating in the intracranial stents market are Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Abbott Laboratories, Terumo Corporation, Balt Extrusion, Acandis GmbH, Phenox GmbH, Rapid Medical Ltd, Penumbra Inc, MicroPort Scientific Corporation, Johnson & Johnson, Cook Medical LLC, Biotronik SE & Co KG, Cardionovum GmbH, InspireMD Inc, Admedes Schuessler GmbH, Kaneka Corporation, W L Gore & Associates Inc, Cerebral Stents.
North America was the largest region in the intracranial stents market in 2025. Asia-Pacific is expected to be the fastest region in the intracranial stents market share during the forecast period. The regions covered in the intracranial stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intracranial stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the intracranial stents market by increasing costs of imported nitinol alloys, polymer coatings, precision manufacturing equipment, and neurointerventional accessories. Neurovascular treatment centers in North America and Europe are most affected due to dependence on imported high-specification stents, while Asia-Pacific faces cost pressures on device manufacturing and distribution. These tariffs are increasing procedure costs and limiting rapid adoption of newer devices. However, they are also promoting domestic stent manufacturing, regional sourcing of materials, and innovation in cost-efficient neurovascular implants.
The intracranial stents market research report is one of a series of new reports that provides intracranial stents market statistics, including intracranial stents industry global market size, regional shares, competitors with a intracranial stents market share, detailed intracranial stents market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial stents industry. This intracranial stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Intracranial stents are tubular devices placed inside blood vessels, canals, or ducts, primarily used for treating intracranial stenosis and brain aneurysms by opening blocked arteries.
The primary types of intracranial stents include self-expanding stents, balloon-expanding stents, and stent-assisted coil embolization. Self-expanding stents expand autonomously after insertion into the intended lumen, such as a blood vessel or organ. Balloon-expanding stents, also known as balloon-expandable stents, offer higher radial stiffness and more precise placement, designed to address restenosis in the iliac artery by opening clogged arteries and restoring blood flow. Stent-assisted coil embolization plays a role in stabilizing coils within an aneurysm, providing support for coil deposition while preventing coil herniation into the parent vessel lumen. These intracranial stents are applied in the treatment of conditions such as brain aneurysms and intracranial stenosis, and find utilization in various sectors including hospitals, ambulatory surgery centers, and others.
The intracranial stents market consists of sales of Neuroform stents, Solitaire, Enterprise, and Leo plus, and Wingspan stent. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Intracranial Stents Market Characteristics
3. Intracranial Stents Market Supply Chain Analysis
4. Global Intracranial Stents Market Trends and Strategies
5. Intracranial Stents Market Analysis of End Use Industries
7. Global Intracranial Stents Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Intracranial Stents Total Addressable Market (TAM) Analysis for the Market
9. Intracranial Stents Market Segmentation
10. Intracranial Stents Market Regional and Country Analysis
11. Asia-Pacific Intracranial Stents Market
12. China Intracranial Stents Market
13. India Intracranial Stents Market
14. Japan Intracranial Stents Market
15. Australia Intracranial Stents Market
16. Indonesia Intracranial Stents Market
17. South Korea Intracranial Stents Market
18. Taiwan Intracranial Stents Market
19. South East Asia Intracranial Stents Market
20. Western Europe Intracranial Stents Market
21. UK Intracranial Stents Market
22. Germany Intracranial Stents Market
23. France Intracranial Stents Market
24. Italy Intracranial Stents Market
25. Spain Intracranial Stents Market
26. Eastern Europe Intracranial Stents Market
27. Russia Intracranial Stents Market
28. North America Intracranial Stents Market
29. USA Intracranial Stents Market
30. Canada Intracranial Stents Market
31. South America Intracranial Stents Market
32. Brazil Intracranial Stents Market
33. Middle East Intracranial Stents Market
34. Africa Intracranial Stents Market
36. Intracranial Stents Market Competitive Landscape and Company Profiles
37. Intracranial Stents Market Other Major and Innovative Companies
40. Intracranial Stents Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Intracranial Stents Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses intracranial stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for intracranial stents? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intracranial stents market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Self-Expanding Stents; Balloon-Expanding Stents2) By Disease Indication: Brain Aneurysm; Intracranial Stenosis
3) By End-User: Hospitals; Ambulatory Surgery Centers; Other End-Users
Subsegments:
1) By Self-Expanding Stents: Neurovascular Aneurysm Stents; Intracranial Stenosis Self-Expanding Stents; Flow-Diverting Stents2) By Balloon Expanding Stents: Bare-Metal Balloon-Expanding Intracranial Stents; Drug-Eluting Balloon-Expanding Intracranial Stents
Companies Mentioned: Medtronic plc; Stryker Corporation; Boston Scientific Corporation; Abbott Laboratories; Terumo Corporation; Balt Extrusion; Acandis GmbH; Phenox GmbH; Rapid Medical Ltd; Penumbra Inc; MicroPort Scientific Corporation; Johnson & Johnson; Cook Medical LLC; Biotronik SE & Co KG; Cardionovum GmbH; InspireMD Inc; Admedes Schuessler GmbH; Kaneka Corporation; W L Gore & Associates Inc; Cerebral Stents
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Intracranial Stents market report include:- Medtronic plc
- Stryker Corporation
- Boston Scientific Corporation
- Abbott Laboratories
- Terumo Corporation
- Balt Extrusion
- Acandis GmbH
- Phenox GmbH
- Rapid Medical Ltd
- Penumbra Inc
- MicroPort Scientific Corporation
- Johnson & Johnson
- Cook Medical LLC
- Biotronik SE & Co KG
- Cardionovum GmbH
- InspireMD Inc
- Admedes Schuessler GmbH
- Kaneka Corporation
- W L Gore & Associates Inc
- Cerebral Stents
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.63 Billion |
| Forecasted Market Value ( USD | $ 1.13 Billion |
| Compound Annual Growth Rate | 15.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
